News on GENFIT from BioPortfolio.com http://www.BioPortfolio.com Consolidated GENFIT news from BioPortfolio.com Wed, 10 Feb 2010 02:27:24 GMT en GENFIT OBTAINS THE RENEWAL OF THE OSEO "INNOVATIVE COMPANY" LABEL AND CONFIRMS ITS ELIGIBILITY FOR FCPI MUTUAL FUNDShttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999890&HITNO=0&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=GENFIT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999890&THISHREF=http://c.moreover.com/click/here.pl%3fz2517717597%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999890&HITNO=0&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=GENFIT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999890&THISHREF=http://c.moreover.com/click/here.pl%3fz2517717597%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: GENFIT OBTAINS THE RENEWAL OF THE OSEO "INNOVATIVE COMPANY" LABEL AND CONFIRMS ITS ELIGIBILITY FOR FCPI MUTUAL FUNDShttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999878&HITNO=1&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=GENFIT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999878&THISHREF=http://c.moreover.com/click/here.pl%3fz2517713859%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999878&HITNO=1&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=GENFIT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999878&THISHREF=http://c.moreover.com/click/here.pl%3fz2517713859%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: GFT505 Positioned as a Leading Drug Candidate in its Therapeutic Areahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3989181&HITNO=2&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=GENFIT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3989181&THISHREF=http://c.moreover.com/click/here.pl%3fz2512051714%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3989181&HITNO=2&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=GENFIT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3989181&THISHREF=http://c.moreover.com/click/here.pl%3fz2512051714%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPipelineReview: GENFIT: GFT505 Positioned as a Leading Drug Candidate in its Therapeutic Areahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3987271&HITNO=3&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=GENFIT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3987271&THISHREF=http://c.moreover.com/click/here.pl%3fz2509741899%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3987271&HITNO=3&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=GENFIT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3987271&THISHREF=http://c.moreover.com/click/here.pl%3fz2509741899%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: GENFIT: GFT505 POSITIONED AS A LEADING DRUG CANDIDATE IN ITS THER...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974312&HITNO=4&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=GENFIT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974312&THISHREF=http://c.moreover.com/click/here.pl%3fz2503401763%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974312&HITNO=4&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=GENFIT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974312&THISHREF=http://c.moreover.com/click/here.pl%3fz2503401763%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: GENFIT's GFT505 exhibits potential to address unmet needs in prediabetic and diabetic patientshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974560&HITNO=5&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=GENFIT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974560&THISHREF=http://c.moreover.com/click/here.pl%3fz2503590867%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974560&HITNO=5&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=GENFIT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974560&THISHREF=http://c.moreover.com/click/here.pl%3fz2503590867%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: GENFIT: GFT505 Positioned as a Leading Drug Candidate in its Therapeutic Areahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974557&HITNO=6&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=GENFIT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974557&THISHREF=http://c.moreover.com/click/here.pl%3fz2503585258%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974557&HITNO=6&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=GENFIT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974557&THISHREF=http://c.moreover.com/click/here.pl%3fz2503585258%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: GENFIT: GFT505 Positioned as a Leading Drug Candidate in its Therapeutic Areahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3976685&HITNO=7&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=GENFIT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3976685&THISHREF=http://c.moreover.com/click/here.pl%3fz2504459004%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3976685&HITNO=7&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=GENFIT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3976685&THISHREF=http://c.moreover.com/click/here.pl%3fz2504459004%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: GENFIT: GFT505 POSITIONED AS A LEADING DRUG CANDIDATE IN ITS THERAPEUTIC AREAhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974156&HITNO=8&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=GENFIT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974156&THISHREF=http://c.moreover.com/click/here.pl%3fz2503315340%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974156&HITNO=8&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=GENFIT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974156&THISHREF=http://c.moreover.com/click/here.pl%3fz2503315340%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: GENFIT: Potential For Combination Of GFT505 With Statinshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3910879&HITNO=9&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=GENFIT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3910879&THISHREF=http://c.moreover.com/click/here.pl%3fz2469203587%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3910879&HITNO=9&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=GENFIT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3910879&THISHREF=http://c.moreover.com/click/here.pl%3fz2469203587%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: GENFIT: Potential For Combination Of GFT505 With Statinshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3911740&HITNO=10&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=GENFIT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3911740&THISHREF=http://c.moreover.com/click/here.pl%3fz2469849651%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3911740&HITNO=10&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=GENFIT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3911740&THISHREF=http://c.moreover.com/click/here.pl%3fz2469849651%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMediLexicon: Genfit gets positive results in pre-clinical study of GFT505 with statinshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3912330&HITNO=11&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=GENFIT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3912330&THISHREF=http://c.moreover.com/click/here.pl%3fz2470155873%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3912330&HITNO=11&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=GENFIT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3912330&THISHREF=http://c.moreover.com/click/here.pl%3fz2470155873%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaBiz: Medical News: GENFIT: Potential For Combination Of GFT505 With Statinshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3911405&HITNO=12&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=GENFIT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3911405&THISHREF=http://c.moreover.com/click/here.pl%3fz2469576868%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3911405&HITNO=12&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=GENFIT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3911405&THISHREF=http://c.moreover.com/click/here.pl%3fz2469576868%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioFind: GENFIT: Potential for Combination of GFT505 with Statinshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3905058&HITNO=13&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=GENFIT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3905058&THISHREF=http://c.moreover.com/click/here.pl%3fz2466006150%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3905058&HITNO=13&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=GENFIT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3905058&THISHREF=http://c.moreover.com/click/here.pl%3fz2466006150%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: GENFIT: Potential for Combination of GFT505 with Statinshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3907769&HITNO=14&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=GENFIT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3907769&THISHREF=http://c.moreover.com/click/here.pl%3fz2467544298%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3907769&HITNO=14&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=GENFIT&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3907769&THISHREF=http://c.moreover.com/click/here.pl%3fz2467544298%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: